Blood and Urine Metabolic Biomarkers Monitor Short-term Dietary Changes
|
By LabMedica International staff writers Posted on 04 Nov 2019 |

Image: Researchers have identified several chemical signatures, detectable in blood and urine, that can accurately measure dietary intake (Photo courtesy of Medical Xpress).
Metabolites found in plasma and urine samples may serve as responsive biomarkers reflecting short-term changes in the habitual diet.
Unhealthy eating patterns have been linked to the increase in obesity and related chronic diseases such as diabetes worldwide. However, existing methods of assessing dietary intake in nutritional epidemiology rely on food frequency questionnaires or dietary records that are prone to bias and selective reporting.
To improve this situation, investigators at McMaster University (Hamilton, ON, Canada) sought to identify metabolites in readily accessible blood or urine samples that would reflect short-term changes in dietary intake. Measurement of those markers would be used to compare the foods provided to study participants to what they reported they had eaten.
Over the course of this study, metabolic phenotyping was performed on 42 healthy participants from the Diet and Gene Intervention (DIGEST) pilot study, a parallel two-arm randomized clinical trial that provided complete diets to all participants. Matching single-spot urine and fasting plasma specimens were collected at baseline, and then following two weeks of either a Prudent or Western diet with a weight-maintaining menu plan designed by a dietician. The Prudent diet was rich in fruits, vegetables, lean meats, and whole grains. The Western diet was rich in trans fats, processed foods, red meat, and sweetened beverages. Targeted and nontargeted metabolite profiling was conducted for two weeks using three complementary analytical platforms.
A modest reduction in systolic and diastolic blood pressure, and total cholesterol was reported for participants following the Prudent diet after two weeks as compared to the Western diet; however, dietary adherence relied on participant self-reporting, and food preparation methods were not standardized.
Overall, 3-methylhistidine and proline betaine concentrations increased in both plasma and urine samples after participants were assigned a Prudent diet with a corresponding decrease in the Western diet group. Similarly, creatinine-normalized urinary imidazole propionate, hydroxypipecolic acid, dihydroxybenzoic acid, and enterolactone glucuronide, as well as plasma ketoleucine and ketovaline increased with a Prudent diet after adjustments for age, sex, and BMI. In contrast, plasma myristic acid, linoelaidic acid, linoleic acid, alpha-linoleic acid, pentadecanoic acid, alanine, proline, carnitine, and deoxycarnitine, as well as urinary acesulfame K increased among participants following a Western diet. Most metabolites were also correlated to changes in the average intake of specific nutrients from self-reported diet records reflecting good adherence to assigned food provisions.
"We were able to detect short-term changes in dietary patterns which could be measured objectively," said senior author Dr. Philip Britz-McKibbin, professor of chemistry and chemical biology at McMaster University. "And it did not take long for these significant changes to become apparent. This has been a major issue in nutritional research and may be one of the main reasons for the lack of real progress in nutritional sciences and chronic disease prevention."
The dietary biomarker study was published in the October 9, 2019, online edition of the journal Nutrients.
Related Links:
McMaster University
Unhealthy eating patterns have been linked to the increase in obesity and related chronic diseases such as diabetes worldwide. However, existing methods of assessing dietary intake in nutritional epidemiology rely on food frequency questionnaires or dietary records that are prone to bias and selective reporting.
To improve this situation, investigators at McMaster University (Hamilton, ON, Canada) sought to identify metabolites in readily accessible blood or urine samples that would reflect short-term changes in dietary intake. Measurement of those markers would be used to compare the foods provided to study participants to what they reported they had eaten.
Over the course of this study, metabolic phenotyping was performed on 42 healthy participants from the Diet and Gene Intervention (DIGEST) pilot study, a parallel two-arm randomized clinical trial that provided complete diets to all participants. Matching single-spot urine and fasting plasma specimens were collected at baseline, and then following two weeks of either a Prudent or Western diet with a weight-maintaining menu plan designed by a dietician. The Prudent diet was rich in fruits, vegetables, lean meats, and whole grains. The Western diet was rich in trans fats, processed foods, red meat, and sweetened beverages. Targeted and nontargeted metabolite profiling was conducted for two weeks using three complementary analytical platforms.
A modest reduction in systolic and diastolic blood pressure, and total cholesterol was reported for participants following the Prudent diet after two weeks as compared to the Western diet; however, dietary adherence relied on participant self-reporting, and food preparation methods were not standardized.
Overall, 3-methylhistidine and proline betaine concentrations increased in both plasma and urine samples after participants were assigned a Prudent diet with a corresponding decrease in the Western diet group. Similarly, creatinine-normalized urinary imidazole propionate, hydroxypipecolic acid, dihydroxybenzoic acid, and enterolactone glucuronide, as well as plasma ketoleucine and ketovaline increased with a Prudent diet after adjustments for age, sex, and BMI. In contrast, plasma myristic acid, linoelaidic acid, linoleic acid, alpha-linoleic acid, pentadecanoic acid, alanine, proline, carnitine, and deoxycarnitine, as well as urinary acesulfame K increased among participants following a Western diet. Most metabolites were also correlated to changes in the average intake of specific nutrients from self-reported diet records reflecting good adherence to assigned food provisions.
"We were able to detect short-term changes in dietary patterns which could be measured objectively," said senior author Dr. Philip Britz-McKibbin, professor of chemistry and chemical biology at McMaster University. "And it did not take long for these significant changes to become apparent. This has been a major issue in nutritional research and may be one of the main reasons for the lack of real progress in nutritional sciences and chronic disease prevention."
The dietary biomarker study was published in the October 9, 2019, online edition of the journal Nutrients.
Related Links:
McMaster University
Latest Molecular Diagnostics News
- New Biomarker Panel to Improve Heart Failure Diagnosis in Women
- Dual Blood Biomarkers Improve ALS Diagnostic Accuracy
- Automated Test Distinguishes Dengue from Acute Fever-Causing Illnesses In 18 Minutes
- High-Sensitivity Troponin I Assay Aids in Diagnosis of Myocardial Infarction
- Fast Low-Cost Alzheimer’s Tests Could Detect Disease in Early and Silent Stages
- Further Investigation of FISH-Negative Tests for Renal Cell Carcinoma Improves Diagnostic Accuracy
- First Direct Measurement of Dementia-Linked Proteins to Enable Early Alzheimer’s Detection
- New Diagnostic Method Detects Pneumonia at POC in Low-Resource Settings
- Blood Immune Cell Analysis Detects Parkinson’s Before Symptoms Appear
- New Diagnostic Marker for Ovarian Cancer to Enable Early Disease Detection

- Urine Test Detects Early Stage Pancreatic Cancer
- Genomic Test Could Reduce Lymph Node Biopsy Surgery in Melanoma Patients
- Urine Test Could Replace Painful Kidney Biopsies for Lupus Patients
- Blood Test Guides Post-Surgical Immunotherapy for Muscle-Invasive Bladder Cancer
- Mitochondrial DNA Mutations from Kidney Stressors Could Predict Future Organ Decline
- Blood Test Could Predict Bariatric Surgery Outcomes in Teenagers
Channels
Clinical Chemistry
view channel
VOCs Show Promise for Early Multi-Cancer Detection
Early cancer detection is critical to improving survival rates, but most current screening methods focus on individual cancer types and often involve invasive procedures. This makes it difficult to identify... Read more
Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
Kidney disease is typically diagnosed through blood or urine tests, often when patients present with symptoms such as blood in urine, shortness of breath, or weight loss. While these tests are common,... Read moreHematology
view channel
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage
Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read moreImmunology
view channel
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
Immunotherapy has revolutionized cancer care by harnessing the immune system to fight tumors, yet predicting who will benefit remains a major challenge. Many patients undergo costly and taxing treatment... Read moreMicrobiology
view channel
15-Minute Blood Test Diagnoses Life-Threatening Infections in Children
Distinguishing minor childhood illnesses from potentially life-threatening infections such as sepsis or meningitis remains a major challenge in emergency care. Traditional tests can take hours, leaving... Read more
High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read morePathology
view channel
AI Tool Improves Accuracy of Skin Cancer Detection
Diagnosing melanoma accurately in people with darker skin remains a longstanding challenge. Many existing artificial intelligence (AI) tools detect skin cancer more reliably in lighter skin tones, often... Read more
Highly Sensitive Imaging Technique Detects Myelin Damage
Damage to myelin—the insulating layer that helps brain cells function efficiently—is a hallmark of many neurodegenerative diseases, age-related decline, and traumatic injuries. However, studying this damage... Read moreTechnology
view channel
AI Model Achieves Breakthrough Accuracy in Ovarian Cancer Detection
Early diagnosis of ovarian cancer remains one of the toughest challenges in women’s health. Traditional tools such as the Risk of Ovarian Malignancy Algorithm (ROMA) can struggle to distinguish between... Read more
Portable Biosensor Diagnoses Psychiatric Disorders Using Saliva Samples
Early diagnosis of psychiatric disorders such as depression, schizophrenia, and bipolar disorder remains one of medicine’s most pressing challenges. Current diagnostic methods rely heavily on clinical... Read more
Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement
Sorting different cell types—such as cancerous versus healthy or live versus dead cells—is a critical task in biology and medicine. However, conventional methods often require labeling, chemical exposure,... Read moreIndustry
view channel
Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics
Co-Diagnostics, Inc. (Salt Lake City, UT, USA) has formed a new artificial intelligence (AI) business unit to integrate the company's existing and planned AI applications into its Co-Dx Primer Ai platform.... Read more








